Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients - PubMed (original) (raw)

Observational Study

. 2020 Nov;23(4):611-620.

doi: 10.1007/s10456-020-09730-0. Epub 2020 May 27.

Coralie L Guerin 3 4, Richard Chocron 5 6, Nader Yatim 7 8, Jeremy Boussier 7 8, Nicolas Gendron 3 9, Lina Khider 10, Jérôme Hadjadj 8 11, Guillaume Goudot 10, Benjamin Debuc 12, Philippe Juvin 13, Caroline Hauw-Berlemont 14, Jean-Loup Augy 14, Nicolas Peron 14, Emmanuel Messas 5 15, Benjamin Planquette 3 16, Olivier Sanchez 3 16, Bruno Charbit 17, Pascale Gaussem 3 18, Darragh Duffy 7 8, Benjamin Terrier 19 20, Tristan Mirault 5 15, Jean-Luc Diehl 3 21

Affiliations

Observational Study

Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients

David M Smadja et al. Angiogenesis. 2020 Nov.

Abstract

Background: Coronavirus disease-2019 (COVID-19), a respiratory disease has been associated with ischemic complications, coagulation disorders, and an endotheliitis.

Objectives: To explore endothelial damage and activation-related biomarkers in COVID-19 patients with criteria of hospitalization for referral to intensive care unit (ICU) and/or respiratory worsening.

Methods: Analysis of endothelial and angiogenic soluble markers in plasma from patients at admission.

Results: Study enrolled 40 consecutive COVID-19 patients admitted to emergency department that fulfilled criteria for hospitalization. Half of them were admitted in conventional wards without any ICU transfer during hospitalization; whereas the 20 others were directly transferred to ICU. Patients transferred in ICU were more likely to have lymphopenia, decreased SpO2 and increased D-dimer, CRP and creatinine levels. In those patients, soluble E-selectin and angiopoietin-2 were significantly increased (p value at 0.009 and 0.003, respectively). Increase in SELE gene expression (gene coding for E-selectin protein) was confirmed in an independent cohort of 32 patients using a whole blood gene expression profile analysis. In plasma, we found a strong association between angiopoetin-2 and CRP, creatinine and D-dimers (with p value at 0.001, 0.001 and 0.003, respectively). ROC curve analysis identified an Angiopoietin-2 cut-off of 5000 pg/mL as the best predictor for ICU outcome (Se = 80.1%, Sp = 70%, PPV = 72.7%, NPV = 77%), further confirmed in multivariate analysis after adjustment for creatinine, CRP or D-dimers.

Conclusion: Angiopoietin-2 is a relevant predictive factor for ICU direct admission in COVID-19 patients. This result showing an endothelial activation reinforces the hypothesis of a COVID-19-associated microvascular dysfunction.

Keywords: Angiogenesis; Angiopoietin-2; Biomarker; COVID-19; E-selectin; Endothelial.

PubMed Disclaimer

Conflict of interest statement

All authors declare nothing to disclose.

Figures

Fig. 1

Fig. 1

Correlations between plasma angiopoietin-2 and sE-selectin levels in COVID-19 patients. R for Kendall rank correlation coefficient

Fig. 2

Fig. 2

E-selectin gene expression profile according to admission of patients in medical ward or ICU versus controls. ICU for intensive care unit; RNA for Ribonucleic Acid; Difference between groups evaluated with Kruskal–Wallis test

Fig. 3

Fig. 3

Correlations between E-selectin and angiopoietin-2 and biological parameters of thrombo-inflammation. a–c correlations between sE-selectin and CRP, plasma creatinine and D-dimers. d–f: correlations between angiopoietin-2 and CRP, plasma creatinine and D-dimers. R for Kendall rank correlation coefficient

Fig. 4

Fig. 4

ROC curve for angiopoietin-2 cut-off in direct ICU admission. Angiopoietin-2 level above 5000 pg/mL was identified using Youden index method as a potential criteria for COVID-19 transfer in ICU (AUC 77.12, 95% CI 62.4–91.9). AUC for area under the curve; CI for confidence interval; PPV for positive predictive value; NPV for negative predictive value. R for Kendall rank correlation coefficient; CRP for C-reactive protein

Similar articles

Cited by

References

    1. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 doi: 10.1016/S0140-6736(20)30566-3. - DOI - PMC - PubMed
    1. Tang N, Li D, Wang X, Sun Z. Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020 doi: 10.1111/jth.14768. - DOI - PMC - PubMed
    1. Poissy J, Goutay J, Caplan M, Parmentier E, Duburcq T, Lassalle F, et al. Pulmonary embolism in COVID-19 patients: awareness of an increased prevalence. Circulation. 2020 doi: 10.1161/CIRCULATIONAHA.120.047430. - DOI - PubMed
    1. Fox S, Akmatbekov A, Harbert J, Li G, Brown G, Vander Heide R. Pulmonary and cardiac pathology in Covid-19: the first autopsy series from New Orleans. medRxiv. 2020 doi: 10.1101/2020.04.06.20050575. - DOI - PMC - PubMed
    1. Zhang H, Zhou P, Wei Y, Yue H, Wang Y, Hu M, et al. Histopathologic changes and SARS-CoV-2 immunostaining in the lung of a patient with COVID-19. Ann Intern Med. 2020;172:629–632. doi: 10.7326/M20-0533. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources